Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-05-03
1998-11-17
Allen, Marianne P.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 72, 435 79, 436518, 436 54, 436545, 530324, 530839, G01N 3353
Patent
active
058374736
ABSTRACT:
The present invention provides a labelled .beta.-amyloid peptide or a labelled active fragment of .beta.-amyloid peptide and methods of using the labelled peptides to screen for agents which affect the deposition of the labelled peptide onto amyloid plaques in tissue samples evidencing the presence of Alzheimer's amyloidosis.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 5221607 (1993-06-01), Cordell et al.
patent: 5434050 (1995-07-01), Maggio et al.
J.D. Sipe, "Amyloidosis", Annu. Rev. Biochem., 61, 947-975 (1992).
D. Allsop et al., "Immunohistomchemical evidence for the derivation of a peptide ligand from the amyloid .beta.-protein precursor of Alzheimer disease", Proc. Natl. Acad. Sci. USA, 85, 2790-2794 (Apr., 1988).
A.E. Bolton et al., "Labelling of Proteins to High Specific Radioactives by Conjugation to a .sup.125 I-Containing Acylating Agent", Biochem J. 133, 529-539 (1973).
D. Burdick, et al., "Assembly and Aggregation Properties of Synthetic Alzheimer's A4/.beta. Amyloid Peptide Analogs", Bio. Chem., 267, 546.dagger.(1992).
J.E. Castano, et al., "In Vitro Formation of Amyloid Fibrils from Two Synthetic Peptides of Different Lengths Homologous to Alzheimer's Disease .beta.-Protein", Biochem. Biophys. Res. Commun., 141, 782-789 (1986).
C.M. Deber, Peptides, Structure and Function, pp. 221-224 and 249-252, Pierce Chemical Company, Rockford, Illinois (1985).
J.F. Flood et al., "Amnestic effects of mice of four synthetic peptides homologous to amyloid .beta. protein from patients with Alheizmers disease", Proc. Natl. Adad. Sci. USA, 88, 3363-3366 (Apr. 1991).
M. Goedert et al., "Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain", The EMBO Journal, 8, 393-399 (1989).
K. Halverson et al. "Molecular Determinants of Amyloid Deposition in Alzheimer's Disease: Conformational Studies of Synthetic .beta.-Protein Fragments", Biochemistry, 29, 2639-2644 (1990).
W.S. Hancock, CRC Handbook of HPLC for the Separation of Amino Acids, Peptides, and Proteins (vol. II), pp. 3-22, 279-286 and 303-312, CRC Press, Inc., Boca Raton, Florida (1984).
P.N. Hawkins et al., "Diagnostic imaging of amyloidosis", European Journal of Nuclear Medicine, 15(8), 436(Abstract No. 149) (1989).
C. Hilbich et al., "Aggregation and Secondary Structure of Synthetic Amyloid .beta.A4 Peptides of Alzheimer's Disease", J. Mol. Biol., 218, 149-163 (1991).
W.M. Hunter et al., "Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity", Nature, 194, 495-496 (May 5, 1962).
C. Joachim, et al., "Amyloid .beta.-protein deposition in tissues other than brain in Alzheimer's disease", Nature, 341, 226-230 (Sep. 21, 1989).
J. Kang, et al., "The precursor of Alzheimer's disease amyloid A4 protien resembles a cell-surface receptor", Nature, 325, 733-736 (Feb. 19, 1987).
R. Katzman et al., "Advances in Alzheimer's disease", The FASEB J., 5, 278-286 (Mar. 1991).
D.A. Kirshner et al., "Synthetic peptide homologous to .beta. protien from Alzheimer disease forms amyloid-like fibrils in vitro", Proc. Natl. Acad. Sci. USA, 84, 6953-6957 (Oct. 1987).
J.-Y. Koh et al., .beta.Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage, Brain Res., 533, 315-320 (1990).
J.E. Maggio, "Tachykinis", Ann. Rev. Neurosc., 11, 13-28 (1988).
J.Maggio, "Tachykinins and Tachykinin Receptors", Abstract of National Institutes of Health Grant No. NS-22961 (Abstract obtained from Dialog's Federal Research in Progress on-line database).
P.W. Mantyh et al., "Substance P receptor binding sites are expressed by glia in vivo after neuronal injury", Proc. Natl. Acad. Sci. USA, 86, 5193-5197 (Jul. 1989).
P.W. Mantyh et al., "Peripheral Nociceptors in Inflammation", Abstract of National Institutes of Health Grant No. NS-23970 (Abstract obtained from Dialog's Federal Research in Progress on-line database).
G.R. Marshall, Peptides, Chemistry and Biology, pp. 198-201 (Beilan et al.), ESCOM Science Publisers, Netherlands (1988).
S.S. Mirra et al., "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease", Neurology, 41, 479-486 (Apr. 1991).
J.C Morris et al., "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease", Neurology, 39, 1159-1165 (Sep., 1989).
B. Muller-Hill et al., "Molecular Biology of Alzheimer's Disease", Ann. Rev. Biochem., 58, 287-307 (1989).
R.J. Perry, "Recent Advances in Neuropathology", Br. Med. Bull., 42, 34-41 (1986).
P.E. Petrides and J.E. Shively, "Microisolation of Biologically Active Polypeptides by Reverse-Phase Liquid Chromatography" and Reverse-Phase HPLC Isolation and Microsequence Analysis in Methods of Protein Microcharacterization, A Practical Handbook; pp. 3-87; Human Press: Clifton, New Jersey (1986).
Remington's, (18th Ed.); "Medical Applications of Radioisotopes, " Pharmaceuticals Science, 33, 634-635, 748-749, Ed. A. R. Gennero (1990).
N.K. Robakis et al., "Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuride plaque amyloid peptides", Proc. Natl. Acad. Sci. USA, 84, 4190-4194 (Jun., 1987).
P. Rovero etal., "Solid-phase synthesis of neurokinin A antagonists", Int. J. Peptide Protein Res., 37, 140-144 (1991).
D.H. Schlesinger, Macromolecular Sequencing and Synthesis, Selected Methods and Applications, pp. 153-220, Alan R. Liss, Inc., New York (1988).
D.J. Selkoe, "The Molecular Pathology of Alzheimer's Disease", Neuron, 6, 487-498 (Apr.1991).
D.J. Selkoe, "Deciphering Alzheimer's Disease: The Amyloid Precursor Protein Yields New Clues", Science, 248, 1058-1060 (Jun. 1990).
D.J. Selkoe, "Biochemistry of Altered Brain Proteins in Alzheimer's Disease", Ann. Rev. Neurosci., 12, 463-490 (1989).
J.M. Stewart et al., Solid-Phase Peptide Synthesis (2nd edition), pp. 74-103 and 147-168, Pierce Chemical Company, Rockford, Illinois (1984).
H.P. Too et al., "Radioimmunoassay of Tachykinins", Meth. Neurosci., 6, 232-241 (1991).
H.P. Too and M.R. Hanley, "Solubilization and characterization of substance P-binding sites from chick brain membranes", Biochems. J., 252, 545-551 (1988).
J.S. Whitsin et al., "Amyloid .beta. Protein Enhances the Survival of Hippocampal Neurons in Vitro", Science, 243, 1488-1490 (Mar. 1989).
C. Wong et al., "Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related", Proc. Natl. Acad. Sci. USA, 82, 8729-8732 (Dec. 1985).
B.A. Yanker et al., "Neurotrophic and Neurotoxic Effects of Amyloid Effects of .beta. Protein: Reversal by Tachykinin Neuropeptides", Science, 250, 279-282 (Oct. 1990).
Maggio John Edward
Mantyh Patrick William
Allen Marianne P.
Duffy Patricia A.
President and Fellows of Harvard College
Regents of the University of Minnesota
LandOfFree
Methods of screening for agents affecting the deposition of .bet does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of screening for agents affecting the deposition of .bet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of screening for agents affecting the deposition of .bet will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-882984